West Valley City, UT3 Active Studies

Multiple Sclerosis Clinical Trials in West Valley City, UT

Find 3 actively recruiting multiple sclerosis clinical trials in West Valley City, UT. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
599
Enrolling

Recruiting Multiple Sclerosis Studies in West Valley City

About Multiple Sclerosis Clinical Trials in West Valley City

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 3 multiple sclerosis clinical trials recruiting participants in West Valley City, UT. These studies are seeking a combined 599 participants. Research is being sponsored by Eli Lilly and Company, GlaxoSmithKline, Corcept Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in West Valley City — FAQ

Are there multiple sclerosis clinical trials in West Valley City?

Yes, there are 3 multiple sclerosis clinical trials currently recruiting in West Valley City, UT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in West Valley City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the West Valley City research site will contact you about next steps.

Are clinical trials in West Valley City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many West Valley City studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 3 active trials in West Valley City are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 22, 2026 from ClinicalTrials.gov